| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 395 / 403 | 2nd | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Alzheimer's Disease
Advances in Alzheimer's Disease is Scopus-indexed (Q4, CiteScore 0.1). Published by IOS Press BV.
Checked against the index lists dated .
ISSN 2210-5727Verify ISSN ↗2210-5735Verify ISSN ↗
Publisher: IOS Press BV
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Alzheimer's Disease indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2024 (also 2020–2022, 2017, 2015, 2011–2012), best quartile Q4, CiteScore 0.1.
What quartile is Advances in Alzheimer's Disease in Scopus?
Advances in Alzheimer's Disease is Q4 in Neurology (clinical) (rank 395 of 403), by CiteScore 2025.
What is the impact factor of Advances in Alzheimer's Disease?
Advances in Alzheimer's Disease is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 2nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.102, quartile Q4, with an H-index of 11.
Who publishes Advances in Alzheimer's Disease and what is its ISSN?
Advances in Alzheimer's Disease is published by IOS Press BV. Its print ISSN is 2210-5727 and its online ISSN is 2210-5735.
Is Advances in Alzheimer's Disease in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Advances in Alzheimer's Disease open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Advances in Alzheimer's Disease? — open metrics via OpenAlex
Advances in Alzheimer's Disease has an h-index of 8 and a 2-year mean of 0.23 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #354 of 403 Scopus journals in Neurology (clinical).
Advances in Alzheimer's Disease published 87 papers in 2024; its busiest recent year was 2011 with 89. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Advances in Alzheimer's Disease? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.